Last reviewed · How we verify
Adult differentiated autologous T-cells
Adult differentiated autologous T-cells is a Biologic drug developed by Sara V. Latorre. It is currently in Phase 1 development.
At a glance
| Generic name | Adult differentiated autologous T-cells |
|---|---|
| Sponsor | Sara V. Latorre |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma (PHASE1, PHASE2)
- Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (PHASE1, PHASE2)
- Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R (PHASE2)
- A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) (PHASE1, PHASE2)
- Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia (PHASE2)
- Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL (PHASE2)
- Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma (PHASE1)
- Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adult differentiated autologous T-cells CI brief — competitive landscape report
- Adult differentiated autologous T-cells updates RSS · CI watch RSS
- Sara V. Latorre portfolio CI
Frequently asked questions about Adult differentiated autologous T-cells
What is Adult differentiated autologous T-cells?
Adult differentiated autologous T-cells is a Biologic drug developed by Sara V. Latorre.
Who makes Adult differentiated autologous T-cells?
Adult differentiated autologous T-cells is developed by Sara V. Latorre (see full Sara V. Latorre pipeline at /company/sara-v-latorre).
What development phase is Adult differentiated autologous T-cells in?
Adult differentiated autologous T-cells is in Phase 1.